Potenza Therapeutics, Inc. — Form D/A
Potenza Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2016-03-17. The offering totals $38.0M, of which $30.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-03-17
- Form: D/A
- Accession: 0001627187-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $38.0M
- Amount sold: $30.0M
- Remaining: $8.0M
- Investors: 6
- Date of first sale: 2014-12-02
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-229558
Issuer
- Name: Potenza Therapeutics, Inc.
- CIK: 0001627187
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1030 MASSSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138
- Phone: 617-588-4150
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Sakae Asanuma | Director | Cambridge, MA |
| Luke Evnin | Director | Watertown, MA |
| Daniel Hicklin | Director | Cambridge, MA |
| Daniel Hicklin | Executive Officer | Cambridge, MA |
| David Cordo | Executive Officer | Cambridge, MA |
| Arnold Oronsky | Director | BOSTON, MA |
| Shunichiro Matsumoto | Director | Cambridge, MA |
| Cynthia Seidel-Dugan | Executive Officer | Cambridge, MA |
| Reid Leonard | Executive Officer | Cambridge, MA |
| Phil Gutry | Director | Baltimore, MD |
| James Wescott | Executive Officer | Boston, MA |
Other filings by this issuer (2)
More